HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Juxtapapillary capillary hemangioma treated by intravitreal injection of bevacizumab combined with posterior subtenon injection of triamcinolone acetonide.

AuthorsNoriko Toyokawa, Hideya Kimura, Shinichiro Kuroda
JournalJapanese journal of ophthalmology (Jpn J Ophthalmol) Vol. 54 Issue 2 Pg. 168-70 (Mar 2010) ISSN: 1613-2246 [Electronic] Japan
PMID20401570 (Publication Type: Case Reports, Letter)
Chemical References
  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Glucocorticoids
  • Vascular Endothelial Growth Factor A
  • Bevacizumab
  • Triamcinolone Acetonide
Topics
  • Adult
  • Angiogenesis Inhibitors (therapeutic use)
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Drug Therapy, Combination
  • Exudates and Transudates
  • Female
  • Fluorescein Angiography
  • Glucocorticoids (therapeutic use)
  • Hemangioma, Capillary (drug therapy, pathology)
  • Humans
  • Injections
  • Optic Disk
  • Optic Nerve Neoplasms (drug therapy, pathology)
  • Retinal Hemorrhage (diagnosis)
  • Tomography, Optical Coherence
  • Triamcinolone Acetonide (therapeutic use)
  • Vascular Endothelial Growth Factor A (antagonists & inhibitors)
  • Vitreous Body

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: